SLC39A7 and breast cancer: This is consistent with recent studies where a siRNA targeting ZIP7 significantly decreased zinc-induced pAKT after 5 minutes of 20 μM zinc treatment in MCF-7 tamoxifen-resistant breast cancer cells [8].